Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence T Park

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|June 6, 2019
Depression in the Primary Care Setting. ReplyLawrence T Park, Carlos A Zarate
The New England Journal of Medicine|February 7, 2019
Depression in the Primary Care SettingLawrence T Park, Carlos A Zarate
Psychiatric Services (Washington, D.C.)|May 6, 2006
Medicare part D and decompensationJennifer M Park, Ravi Hariprasad, Lawrence T Park
Focus (American Psychiatric Publishing)|January 25, 2020
Ketamine for Treatment-Resistant Mood DisordersLawrence T Park, Tolulope B Falodun, Carlos A Zarate
CNS Drugs|April 27, 2021
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current StatusIoline D Henter, Lawrence T Park, Carlos A Zarate
CNS Drugs|January 11, 2022
Authors' Reply to Pappagallo et al.: Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status"Ioline D Henter, Lawrence T Park, Carlos A Zarate
Expert Opinion on Pharmacotherapy|July 12, 2021
Key considerations in the pharmacological management of treatment-resistant depressionMani Yavi, Ioline D Henter, Lawrence T Park, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 17, 2007
Evaluation and treatment of poor sleepLawrence T Park, John D Matthews, Guy Maytal, et al.
The Journal of Clinical Psychiatry|August 7, 2020
Clinical Trials With Suicidal Individuals Can Be Conducted SafelyElizabeth D Ballard, Lawrence T Park, Maryland Pao, et al.
BMC Psychiatry|November 3, 2019
Research on the pathophysiology, treatment, and prevention of suicide: practical and ethical issuesAllison C Nugent, Elizabeth D Ballard, Lawrence T Park, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|June 6, 2019
Depression in the Primary Care Setting. ReplyLawrence T Park, Carlos A Zarate
The New England Journal of Medicine|February 7, 2019
Depression in the Primary Care SettingLawrence T Park, Carlos A Zarate
Psychiatric Services (Washington, D.C.)|May 6, 2006
Medicare part D and decompensationJennifer M Park, Ravi Hariprasad, Lawrence T Park
Focus (American Psychiatric Publishing)|January 25, 2020
Ketamine for Treatment-Resistant Mood DisordersLawrence T Park, Tolulope B Falodun, Carlos A Zarate
CNS Drugs|April 27, 2021
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current StatusIoline D Henter, Lawrence T Park, Carlos A Zarate
CNS Drugs|January 11, 2022
Authors' Reply to Pappagallo et al.: Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status"Ioline D Henter, Lawrence T Park, Carlos A Zarate
Expert Opinion on Pharmacotherapy|July 12, 2021
Key considerations in the pharmacological management of treatment-resistant depressionMani Yavi, Ioline D Henter, Lawrence T Park, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 17, 2007
Evaluation and treatment of poor sleepLawrence T Park, John D Matthews, Guy Maytal, et al.
The Journal of Clinical Psychiatry|August 7, 2020
Clinical Trials With Suicidal Individuals Can Be Conducted SafelyElizabeth D Ballard, Lawrence T Park, Maryland Pao, et al.
BMC Psychiatry|November 3, 2019
Research on the pathophysiology, treatment, and prevention of suicide: practical and ethical issuesAllison C Nugent, Elizabeth D Ballard, Lawrence T Park, et al.
Pageof 5